Yüklüyor......
Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and severe microthrombi and microvascular obliterative disease. It is hypothesized that those patients with...
Kaydedildi:
| Yayımlandı: | Pulm Circ |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686637/ https://ncbi.nlm.nih.gov/pubmed/33282201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020970369 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|